Maplight Therapeutics Inc (MPLT)

Jan 09, 2026

MapLight Therapeutics stock rises after accelerating clinical trial timelines By Investing.com - Investing.com Canada

Jan 09, 2026

Jan 09, 2026

MapLight Therapeutics accelerates timeline for Phase 2 trial results By Investing.com - Investing.com Nigeria

Jan 09, 2026

Jan 09, 2026

MapLight updates trial timelines and highlights CNS pipeline - TipRanks

Jan 09, 2026

Jan 09, 2026

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 - The Manila Times

Jan 09, 2026

Jan 09, 2026

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 - GlobeNewswire Inc.

Jan 09, 2026

Jan 06, 2026

FDA grants fast track designation to MapLight’s Alzheimer’s drug By Investing.com - Investing.com Nigeria

Jan 06, 2026

Jan 05, 2026

Maplight Therapeutics (MPLT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Jan 05, 2026

Jan 05, 2026

MapLight Therapeutics' Alzheimer's Psychosis Drug Granted FDA Fast Track Status - Nasdaq

Jan 05, 2026

Jan 05, 2026

MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis - The Manila Times

Jan 05, 2026

Dec 30, 2025

MapLight’s phase 2 Alzheimer’s psychosis trial marks a key milestone for MPLT investors - MSN

Dec 30, 2025

Dec 26, 2025

What is the current Price Target and Forecast for MapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research

Dec 26, 2025

Dec 23, 2025

MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors - TipRanks

Dec 23, 2025

Dec 22, 2025

MapLight Therapeutics Earnings Notes - Trefis

Dec 22, 2025

Dec 22, 2025

MapLight Therapeutics advances CNS drug pipeline - MSN

Dec 22, 2025

Dec 22, 2025

MapLight’s ML-004 Autism Extension Study: What Ongoing Safety Data Mean for Investors - TipRanks

Dec 22, 2025

Dec 21, 2025

MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to S&P TMI Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

Aktis Oncology files for US IPO as biotech listings rebound - whbl.com

Dec 20, 2025

Dec 18, 2025

MapLight2025 Funding Rounds & List of Investors - Tracxn

Dec 18, 2025

Dec 18, 2025

MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to Russell 2000 Growth Index - marketscreener.com

Dec 18, 2025

Dec 17, 2025

SandboxAQ and MapLight join forces on CNS - The Pharma Letter

Dec 17, 2025

Dec 17, 2025

6 Biotechs That Could Be Big Pharma’s Next M&A Target - BioSpace

Dec 17, 2025

Dec 16, 2025

SandboxAQ and MapLight Therapeutics Partner on Novel CNS Therapies - HPCwire

Dec 16, 2025

Dec 16, 2025

SandboxAQ and MapLight form $200 million CNS drug discovery alliance By Investing.com - Investing.com Nigeria

Dec 16, 2025

Dec 16, 2025

SandboxAQ and MapLight form $200 million CNS drug discovery alliance - Investing.com

Dec 16, 2025

Dec 16, 2025

MapLight links up with SandboxAQ to pursue AI-discovered CNS treatments - Axios

Dec 16, 2025

Dec 16, 2025

SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies - The Manila Times

Dec 16, 2025

Dec 16, 2025

Sandboxaq And Maplight Therapeutics Announce Collaboration To Discover And Develop Novel CNS Therapies - TradingView — Track All Markets

Dec 16, 2025

Dec 12, 2025

MapLight Therapeutics to join Russell 3000, Russell 2000 and Russell Microcap indexes - MSN

Dec 12, 2025

Dec 08, 2025

Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO - MSN

Dec 08, 2025

Dec 07, 2025

MapLight Therapeutics completes IPO and raises $296.5M - MSN

Dec 07, 2025

Dec 06, 2025

Analysts Offer Insights on Healthcare Companies: MapLight Therapeutics, Inc. (MPLT) and Halozyme (HALO) - The Globe and Mail

Dec 06, 2025

Dec 06, 2025

Maplight Therapeutics (MPLT) Stock Trends and Sentiment 2025 - MarketBeat

Dec 06, 2025

Dec 05, 2025

symbol__ Stock Quote Price and Forecast - CNN

Dec 05, 2025

Dec 05, 2025

Adversity is less terrifying than hope: MapLight Therapeutics Inc (MPLT) - setenews.com

Dec 05, 2025

Dec 04, 2025

MapLight Therapeutics Advances CNS Drug Pipeline - TipRanks

Dec 04, 2025

Dec 04, 2025

Florida key to BMS slip in ADP? Acadia sails ahead - BioWorld MedTech

Dec 04, 2025

Dec 04, 2025

Maplight Therapeutics (MPLT) Earnings Date and Reports 2026 - MarketBeat

Dec 04, 2025

Dec 04, 2025

Maplight Therapeutics reports third quarter financial results - marketscreener.com

Dec 04, 2025

Dec 04, 2025

MapLight Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com

Dec 04, 2025

Dec 04, 2025

MapLight Therapeutics Completes IPO and Raises $296.5M - TipRanks

Dec 04, 2025

Dec 04, 2025

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress - The Manila Times

Dec 04, 2025

Dec 04, 2025

MapLight Therapeutics, Inc. SEC 10-Q Report - TradingView

Dec 04, 2025

Dec 04, 2025

MPLT: Clinical pipeline advances and robust IPO funding position operations through 2027 - TradingView — Track All Markets

Dec 04, 2025

Dec 03, 2025

Positive Outlook on MapLight Therapeutics Amid ADEPT-2 Study Continuation and Upcoming Catalysts - TipRanks

Dec 03, 2025

Dec 03, 2025

MapLight stock rises as Jefferies reiterates Buy rating on schizophrenia drug By Investing.com - Investing.com South Africa

Dec 03, 2025